ConductScience.org, home

Paper36039739

HMGB1 increases RAGE expression in vascular smooth muscle cells via ERK and p-38 MAPK-dependent pathways.

Jang EJ and 6 others. Korean J Physiol Pharmacol, 2022. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. HMGB1 increases RAGE expression in vascular smooth muscle cells via ERK and p-38 MAPK-dependent pathways. Papers, record 36039739. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36039739

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HMGB1 increases RAGE expression in vascular smooth muscle cells via ERK and p-38 MAPK-dependent pathways.
PubMed
Journal
Korean J Physiol Pharmacol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
1.59
iCite
Revised in PubMed
2022-09-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jang EJEun Jeong
2Kim HHeejeong
3Baek SESeung Eun
4Jeon EYEun Yeong
5Kim JWJi Won
6Kim JYJu Yeon
7Kim CDChi Dae

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121219181HMGB1 is a therapeutic target for sterile inflammation and infection.Annu Rev Immunol2011https://conductscience.org/library/papers/21219181PubMed
226505215Rap1 induces cytokine production in pro-inflammatory macrophages through NFκB signaling and is highly expressed in human atherosclerotic lesions.Cell Cycle2015https://conductscience.org/library/papers/26505215PubMed
319564572The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.J Leukoc Biol2009https://conductscience.org/library/papers/19564572PubMed
427579780High Mobility Group Box 1 Mediates Interferon-γ-Induced Phenotypic Modulation of Vascular Smooth Muscle Cells.J Cell Biochem2017https://conductscience.org/library/papers/27579780PubMed
511413090Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats.Circulation2001https://conductscience.org/library/papers/11413090PubMed
615374849Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines.Arterioscler Thromb Vasc Biol2004https://conductscience.org/library/papers/15374849PubMed
717060403Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein.FASEB J2006https://conductscience.org/library/papers/17060403PubMed
830954689HMGB1 enhances AGE-mediated VSMC proliferation via an increase in 5-LO-linked RAGE expression.Vascul Pharmacol2019https://conductscience.org/library/papers/30954689PubMed
924225188Chronic allograft dysfunction: a model disorder of innate immunity.Biomed J2013https://conductscience.org/library/papers/24225188PubMed
1011042467RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes.Trends Endocrinol Metab2000https://conductscience.org/library/papers/11042467PubMed
1123929500Local extension of HMGB1 in atherosclerotic lesions of human main cerebral and carotid arteries.Histol Histopathol2014https://conductscience.org/library/papers/23929500PubMed
1226221589Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling.Biomed Res Int2015https://conductscience.org/library/papers/26221589PubMed
1311581294The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.J Clin Invest2001https://conductscience.org/library/papers/11581294PubMed
1418276911Role of smooth muscle cells in the initiation and early progression of atherosclerosis.Arterioscler Thromb Vasc Biol2008https://conductscience.org/library/papers/18276911PubMed
158630372Biologic basis for interleukin-1 in disease.Blood1996https://conductscience.org/library/papers/8630372PubMed
1623318458The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics.Oncogene2014https://conductscience.org/library/papers/23318458PubMed
1724984831HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs.Am J Transplant2014https://conductscience.org/library/papers/24984831PubMed
1825862459HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2.Mol Cell Biochem2015https://conductscience.org/library/papers/25862459PubMed
1915950204Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis.Cardiovasc Res2005https://conductscience.org/library/papers/15950204PubMed
2026248341Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function.PLoS One2015https://conductscience.org/library/papers/26248341PubMed

See all 27 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42931871HMGB1 mediates regorafenib-induced hypertension by regulating vascular smooth muscle cell phenotypic transformation.Cell Biol Toxicol2026https://conductscience.org/library/papers/42931871PubMed
42657492HMGB1 as a danger signal in vascular remodeling.Korean J Physiol Pharmacol2026https://conductscience.org/library/papers/42657492PubMed
42470822Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases.Pharmacol Rev2026https://conductscience.org/library/papers/42470822PubMed
41624624Potential effect and mechanism of ultrashort wave therapy in mice with chronic rhinosinusitis.Biomed Rep2026https://conductscience.org/library/papers/41624624PubMed
41152992Role of vascular smooth muscle phenotypic transformation induced by histone modifications in the development of abdominal aortic aneurysms.Clin Epigenetics2025https://conductscience.org/library/papers/41152992PubMed
41009351Inhibition of the HMGB1-RAGE Axis Attenuates Microglial Inflammation and Ameliorates Hypoxia-Induced Cognitive Impairment.Int J Mol Sci2025https://conductscience.org/library/papers/41009351PubMed
39925465Relationship Between Serum HMGB1 and RAGE Levels and Restenosis in Type 2 Diabetes Mellitus Patients Complicated With Lower Extremity Vascular Disease: A Retrospective Study.Diabetes Metab Syndr Obes2025https://conductscience.org/library/papers/39925465PubMed
39539178Echinochrome A inhibits HMGB1-induced vascular smooth muscle cell migration by suppressing osteopontin expression.Korean J Physiol Pharmacol2025https://conductscience.org/library/papers/39539178PubMed
39467714Protective effect of 6'-Sialyllactose on LPS-induced macrophage inflammation via regulating Nrf2-mediated oxidative stress and inflammatory signaling pathways.Korean J Physiol Pharmacol2024https://conductscience.org/library/papers/39467714PubMed
39395136Targeting RAGE-signaling pathways in the repair of rotator-cuff injury.Mol Cell Biochem2025https://conductscience.org/library/papers/39395136PubMed
39198225Biophysically stressed vascular smooth muscle cells express MCP-1 via a PDGFR-β-HMGB1 signaling pathway.Korean J Physiol Pharmacol2024https://conductscience.org/library/papers/39198225PubMed
38784044Quantitative Assessment of Intracellular Effectors and Cellular Response in RAGE Activation.Arch Intern Med Res2024https://conductscience.org/library/papers/38784044PubMed
36235700Structural Characterization of a Pleurotus sajor-caju Polysaccharide and Its Neuroprotection Related to the Inhibition of Oxidative Stress.Nutrients2022https://conductscience.org/library/papers/36235700PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36039739

GET https://conductscience.org/api/papers/v1/36039739/references?page=2